IRIS
SACCO, RODOLFO, COSMA, DAMIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.340
EU - Europa 1.972
AS - Asia 1.613
SA - Sud America 239
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 2
Totale 6.201
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.303
CN - Cina 559
SG - Singapore 518
IE - Irlanda 515
UA - Ucraina 315
SE - Svezia 311
RU - Federazione Russa 303
BR - Brasile 193
VN - Vietnam 163
HK - Hong Kong 123
IT - Italia 115
IN - India 106
DE - Germania 105
FR - Francia 87
GB - Regno Unito 85
FI - Finlandia 82
TR - Turchia 63
CA - Canada 18
AR - Argentina 17
BE - Belgio 17
MX - Messico 12
EU - Europa 11
CO - Colombia 10
TW - Taiwan 10
BD - Bangladesh 9
JP - Giappone 8
IQ - Iraq 7
PL - Polonia 7
ZA - Sudafrica 7
EC - Ecuador 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
ID - Indonesia 5
PH - Filippine 5
VE - Venezuela 5
AL - Albania 4
AT - Austria 4
ES - Italia 4
MA - Marocco 4
PK - Pakistan 4
SA - Arabia Saudita 4
CL - Cile 3
DO - Repubblica Dominicana 3
KE - Kenya 3
KZ - Kazakistan 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
IR - Iran 2
KR - Corea 2
NL - Olanda 2
OM - Oman 2
PA - Panama 2
SN - Senegal 2
AU - Australia 1
BG - Bulgaria 1
BW - Botswana 1
CH - Svizzera 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KY - Cayman, isole 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
TH - Thailandia 1
UY - Uruguay 1
Totale 6.201
Salva come PNG Salva come JPEG
Città #
Dublin 515
San Jose 330
Chandler 323
Singapore 266
Jacksonville 220
Nyköping 195
Dearborn 148
Beijing 147
Ashburn 141
Hong Kong 123
Nanjing 114
Wilmington 93
Dong Ket 75
Ann Arbor 65
Santa Clara 64
New York 54
San Mateo 54
Princeton 53
Lauterbourg 52
Woodbridge 50
Moscow 49
Nanchang 38
Helsinki 35
Boardman 31
Munich 31
Ho Chi Minh City 29
Philadelphia 28
Dallas 26
Hanoi 24
Cedar Knolls 23
Shenyang 23
Los Angeles 21
Tianjin 20
Changsha 19
Stevenage 19
São Paulo 18
Brussels 17
Jiaxing 17
Hebei 16
Des Moines 13
Kunming 13
Hilden 12
Guangzhou 10
Banqiao 9
Belo Horizonte 9
Rio de Janeiro 9
Brasília 8
Foggia 8
Hangzhou 8
Nuremberg 8
Orem 8
Toronto 8
Council Bluffs 7
Milan 7
Rome 7
Shanghai 7
Changchun 6
Chennai 6
Chicago 6
Frankfurt am Main 6
Kocaeli 6
London 6
Ningbo 6
The Dalles 6
Tokyo 6
Auburn Hills 5
Bari 5
Borås 5
Curitiba 5
Da Nang 5
Las Vegas 5
Leawood 5
Porto Alegre 5
Warsaw 5
Augusta 4
Brooklyn 4
Cluj 4
Fairfield 4
Hillsboro 4
Houston 4
Jinan 4
Johannesburg 4
Ninh Bình 4
Pune 4
San Francisco 4
Seattle 4
Taizhou 4
Turku 4
Zhengzhou 4
Asunción 3
Baghdad 3
Buffalo 3
Campo Grande 3
Can Tho 3
Lanzhou 3
Manchester 3
New Delhi 3
Orange 3
Quezon City 3
Shenzhen 3
Totale 3.909
Salva come PNG Salva come JPEG
Nome #
Chemioembolizzazione con particelle embolizzanti a rilascio farmacologico (DEB-TACE) vs tecnica convenzionale (TACE): risposta tumorale e sopravvivenza in pazienti con HCC 259
228 CONVENTIONAL TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (C-TACE) VERSUS DOXORUBICIN ELUTING BEAD (DEB)-TACE FOR HEPATOCELLULAR CARCINOMA: ASSESSMENT OF CLINICAL IMPACT-SHORT AND LONG-TERM PROSPECTIVE STUDY 224
392 HBeAg defective mutants in active/inactive anti-HBe positive HBV carriers: Possible role of pre-core initiation mutants 161
526 Liver stiffness measured by transient elastography. The influence of biochemical activity 159
The tightly regulated inducible expression of the core protein of hepatitis C virus modulates Fas- and TNF alpha-mediated apoptosis in human liver cells 153
504 HBV quasispecies selected during lamivudine treatment may contribute to adefovir dipivoxil resistance 148
[GLUTATHIONE IN THE TREATMENT OF CHRONIC FATTY LIVER DISEASES] 146
Cost effective prediction of sustained response to IFN Alfa-2B or PEG-IFN Alfa 2B plus Ribavirin computing infected cells dynamics by early ALT and HCV-RNA decline 132
Transient elastography improves the management of CHB patients 129
Antiapoptotic regulation by hepatitis C virus core protein through up-regulation of inhibitor of caspase-activated DNase. 129
Early prediction of sustained response in chronic hepatitis C patients treated with pegilated IFNs (A-2B or A-2A) plus ribavirin using a bio-mathematical model that describes the dynamics of infected cells 128
HBeAg defective mutants in active/inactive anti-HBe positive HBsAg carriers: possible role of pre-core initiation mutants 127
Liver inflammation and acute respiratory distress syndrome in a patient receiving hepatitis B vaccine: a possible relationship? 123
EARLY AND COST EFFECTIVE PREDICTION OF TREATMENT OUTCOME WITH IFNA2B OR PEG-IFNA2B PLUS RIBAVIRIN COMPUTING INFECTED CELLS DYNAMICS BY ALT AND HCV-RNA DECLINE DURING THE FIRST MONTH 121
Entecavir for Hepatitis B Virus Flare Treatment in Patients with Crohn’s Disease 120
Hepatitis C virus serotypes in haemodialysis patients in South-East Italy. 119
Survival after transarterial chemoembolization in early-stage HCC patients excluded from liver transplantation: a prospective cohort study 118
Complete response for advanced liver cancer during sorafenib therapy: case report. 118
Selective transcatheter arterial chemoembolization for hepatocellular carcinoma: Evaluation of clinical impact-short and long-term prospective study 117
Hepatitis C virus serotypes and sources of infection in patients with HCV-related chronic liver disease from one geographical area in southeast Italy. 116
Liver stiffness measured by transient elastography: The influence of biochemical activity 114
Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma. 114
Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: a cohort study 113
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment. 111
Pulmonary or otolaryngologic extraesophageal manifestations in patients with gastroesophageal reflux disease 110
The prevalence of hepatitis C virus types in patients of the same geographic area, according to the source of infection and liver disease. 109
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. 109
sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology. 108
MONITORING LIVER STIFFNESS: A NEW TOOL TO MEASURE LIVER FIBROSIS DURING THERAPY 107
Distribution of hepatitis C virus serotypes and duration of infection in HCV infected subjects from a geographical area in Southeast Italy. 106
Feasibility and safety of granulocytapheresis in Crohn’s disease: A prospective color study 106
Monitoring liver elasticity: a new tool to measure liver fibrosis during therapy 103
Efficacy of hemostatic powders in lower gastrointestinal bleeding: Clinical series and literature review 103
Hepatitis C virus-RNA, immunoglobulin M anti-HCV and risk factors in haemodialysis patients. 101
Conventional vs Doxorubicin Eluting Bead Transcatheter Chemoembolization for Hepatocellular Carcinoma. 101
A new model of HBV infection dynamics shows a multiphasic decay of viral load and a short half-life of circulating virus in anti-HBe positive patients treated with lamivudine 100
Adherence to AASLD guidelines in the real world of HCC in Italy preliminary results of a prospective study 96
Endotics system versus colonscopy for the detection of polyps a randomised trial 95
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study. 91
Quantitative Determination of Hepatitis C Core Antigen in Therapy Monitoring for Chronic Hepatitis C. 89
Effectiveness of hemostatic powders in lower gastrointestinal bleeding: a systematic review and meta-analysis 87
TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma 87
Partial Response and Cardiovascular Recovery after Sorafenib Dose Reduction in a Multinodular HCC Patient. 84
Utilization of Hepatocellular Carcinoma Surveillance Programs in Patients With Cirrhosis: A Systematic Review and Meta-Analysis 82
Endotics system vs colonoscopy for the detection of polyps 80
Valutazione dell’impatto sulla funzionalità epatica della chemioembolizzazione in pazienti con epatocarcinoma tecnica convenzionale Versus particelle embolizzanti. 80
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 78
Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma 78
Efficacy of combined transarterial radioembolization and sorafenib in the treatment of hepatocarcinoma: A meta-analysis 75
Towards a tailored systemic therapy for liver cancer 72
Sustained response to Interferon-ribavirin combination therapy in chronich hepatitis C predicted by a model of viral dynamics using both HCV-RNA and alanine amino transferase. 71
Bright Luminal Sign on High b-Value Diffusion-Weighted Magnetic Resonance Enterography Imaging as a New Biomarker to Predict Fibrotic Strictures in Crohn’s Disease Patients: A Retrospective Preliminary Study 68
Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review 57
Prognostic Role of Post-Induction Fecal Calprotectin Levels in Patients with Inflammatory Bowel Disease Treated with Biological Therapies 57
Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials 57
Cholangiocarcinoma in the Era of Immunotherapy 56
Stereotactic body radiotherapy vs radiofrequency ablation for the treatment of hepatocellular carcinoma: a meta-analysis 56
Target therapies plus somatostatin analogues in NETs: a network meta-analysis 49
Reply to Lissing et al. Comment on "Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947" 43
An Unusual Case of Herpes Zoster of the Hand Following a Physical Trauma: Case Report and Literature Review 26
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 17
Totale 6.293
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.691
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021189 0 0 0 0 0 0 0 0 0 100 7 82
2021/2022365 53 4 9 8 54 25 16 21 47 37 7 84
2022/20231.416 116 79 82 112 71 124 6 133 620 10 40 23
2023/2024183 42 14 4 4 16 62 2 5 2 14 1 17
2024/2025894 36 7 12 28 61 103 89 50 286 42 80 100
2025/20261.559 110 99 194 210 132 103 382 195 81 53 0 0
Totale 6.293